Empagliflozin-associated Armanni-Ebstein lesions in IgA nephropathy - PubMed
3 hours ago
- #IgA nephropathy
- #Armanni-Ebstein lesion
- #SGLT2 inhibitor
- Empagliflozin is associated with Armanni-Ebstein lesions in IgA nephropathy.
- The study is published with PMID: 41824604 and DOI: 10.1016/j.kint.2025.12.032.
- Keywords include Armanni-Ebstein lesion, IgA nephropathy, SGLT2 inhibitor, empagliflozin, and tubular injury.
- Full text sources and other resources are available via LinkOut.